tiprankstipranks
2seventy bio Halts KarMMa-9 Study, Forecasts Strong Abecma Sales
PremiumCompany Announcements2seventy bio Halts KarMMa-9 Study, Forecasts Strong Abecma Sales
4M ago
2seventy Bio to discontinue enrollment in Phase 3 KarMMa-9 study of Abecma
Premium
The Fly
2seventy Bio to discontinue enrollment in Phase 3 KarMMa-9 study of Abecma
4M ago
2seventy Bio sees Q3 Abecma U.S. revenue growth ~ 30% vs. Q2
Premium
The Fly
2seventy Bio sees Q3 Abecma U.S. revenue growth ~ 30% vs. Q2
4M ago
2seventy Bio announces sale of Hemophilia A candidate for up to $40M
PremiumThe Fly2seventy Bio announces sale of Hemophilia A candidate for up to $40M
7M ago
2seventy bio’s Board Elections and Financial Oversight Update
Premium
Company Announcements
2seventy bio’s Board Elections and Financial Oversight Update
8M ago
2seventy Bio downgraded to Sell from Neutral at Goldman Sachs
Premium
The Fly
2seventy Bio downgraded to Sell from Neutral at Goldman Sachs
8M ago
2seventy bio’s Abecma Wins FDA Approval for Multiple Myeloma
PremiumCompany Announcements2seventy bio’s Abecma Wins FDA Approval for Multiple Myeloma
10M ago
Bristol Myers, 2seventy Bio’s Abecma approved by U.S. FDA
Premium
The Fly
Bristol Myers, 2seventy Bio’s Abecma approved by U.S. FDA
10M ago
Fly Insider: 2seventy bio, Coinbase among week’s notable insider trades
Premium
The Fly
Fly Insider: 2seventy bio, Coinbase among week’s notable insider trades
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100